Initiated IDE161 Phase 1 expansion based on preliminary tumor shrinkage observed in multiple HRD solid tumor patients, including an endometrial cancer subject with a first imaging assessment of a ...
Feasibility of bevacizumab (BEV) plus chemotherapy in heavily pretreated ovarian cancer (OC) patients (pts): A retrospective study. Background: Rising serum cancer antigen 125 (CA-125) trends within ...
Recurrent epithelial ovarian carcinoma is considered an incurable disease, and second-line chemotherapy is mainly considered for palliation of symptoms and extension of survival. There are a growing ...
Risk Factors for Heart Failure Among Pan-European Childhood Cancer Survivors: A PanCareSurFup and ProCardio Cohort and Nested Case-Control Study In addition to HRD/BRCA status, the tumor primary ...
Type 2 diabetes mellitus is a risk factor for pancreatic cancer which is increasing worldwide. A research group from Turkey has found that the use of a tumor marker, Ca 19-9, in diabetics with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results